Christopher Gibson

Director

Christopher Gibson (Director) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales), most often in Recursion Pharmaceuticals, Inc. (RXRX). The largest single filing was $604K of RXRX (100,000 sh × $6.04, as filed), executed Oct 10 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 17 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$3.4M

shares × price, as filed

Last traded

Jun 5

Filed Jun 5

Median ADV $67.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $10.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 17 filings

Sector per market data · by filing · past 12 months

Most traded names

RXRX

Recursion Pharmaceuticals, Inc. RXRX · 0 buys · 27 sells 27 filings

Recent filings

RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $145K
40,000 sh × $3.62
Exec Jun 5
Filed Jun 5 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $123K
40,000 sh × $3.08
Exec May 22
Filed May 27 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $135K
40,000 sh × $3.37
Exec May 7
Filed May 8 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $144K
40,000 sh × $3.61
Exec Apr 22
Filed Apr 24 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $124K
40,000 sh × $3.10
Exec Apr 7
Filed Apr 8 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $130K
40,000 sh × $3.25
Exec Mar 23
Filed Mar 25 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $138K
40,000 sh × $3.46
Exec Feb 19
Filed Feb 19 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $165K
40,000 sh × $4.12
Exec Feb 4
Filed Feb 6 · 5:30 PM ET More filings →